Table 3.
Comparison of Outcomes in Different Sarcopenic Cohorts
| Total, n = 152 | Male, n = 89 | Female, n = 63 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sarcopenia (n = 59) |
Sarcopenic Overweight/Obesity (n=26) |
Normal (n = 93) |
P* | P# | TPAI ≤4.78 (n = 31) |
TPAI>4.78 (n = 58) |
P | TPAI ≤3.46 (n = 28) |
TPAI>3.46 (n = 35) |
P | |
| Major complications, n(%) | 24 (40.7) | 11 (42.3) | 7 (7.5) | 0.000 | 0.000 | 17 (54.8) | 6 (10.3) | 0.000 | 7 (25.0) | 1 (2.9) | 0.025 |
| Re-operation, n(%) | 11 (18.6) | 5 (19.2) | 3 (3.2) | 0.001 | 0.015 | 9 (29.0) | 3 (5.2) | 0.005 | 2 (7.1) | 0 (0.0) | 0.337 |
| In-hospital mortality, n(%) | 4 (6.8) | 1 (3.8) | 1 (1.1) | 0.055 | 0.378 | 4 (12.9) | 1 (1.7) | 0.048 | – | – | – |
| LOS, days | 33.4±21.2 | 32.2±15.1 | 24.1±15.4 | 0.004 | 0.019 | 36.6±24.0 | 23.8±14.6 | 0.001 | 29.9±17.4 | 24.6±16.9 | 0.232 |
| Total hospital cost, USD | 22,761.8± 9158.5 | 25,190.5±7095.6 | 16,668.0± 6542.3 | 0.003 | 0.000 | 25,445.6± 9710.1 | 17,144.8± 7339.0 | 0.002 | 18,288.5± 6212.9 | 15,816.5± 4845.6 | 0.270 |
Notes: *Comparison between sarcopenia and normal groups. #Comparison between sarcopenic overweight/obesity and normal groups.
Abbreviations: TPAI, total psoas area index; LOS, length of stay; USD, United States Dollar.